Dr. Lori Muffly, MD, MS, is an Associate Professor of Medicine at Stanford University in the Division of Blood and Marrow Transplantation and Cellular Therapy. Dr. Muffly is a clinician and clinical investigator whose research includes both health outcomes and clinical trials pertaining to adults with acute leukemia. Her clinical practice serves adults across Northern California with advanced acute leukemias who require hematopoietic cell transplantation and other cellular immunotherapies.

She has a specific research interest in improving access to specialty cancer care and reducing health disparities in young adults with acute lymphoblastic leukemia and has published extensively on these topics. She also serves as the PI of multiple investigator-initiated health outcomes studies and clinical trials, including studies evaluating measurable residual disease in adult acute lymphoblastic leukemia, novel chimeric antigen receptor T cell studies for acute leukemia, and she leads a recently established real world consortium investigating outcomes following cellular therapies administered to adults with acute lymphoblastic leukemia.